Welcome to the Wyoming Chapter of the American College of Cardiology
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!. For more information and to register, please visit:
ACC Rockies Chapter Meeting 2025
|
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- ACCEL Lite: Does Eliminating Coffee Avoid Fibrillation (DECAF) TrialCaffeinated coffee may reduce the risk of atrial fibrillation through several proposed mechanisms, including improved autonomic balance, antioxidant effects, and enhanced vascular function.
- ACC.26 Convocation Incoming President’s Address: Roxana Mehran, MD, FACCIncoming ACC President Roxana Mehran reflects on her journey, honors mentors and calls the cardiovascular community to lead with innovation, compassion and collaboration.
- ACC.26 Convocation Outgoing President’s Address: Christopher Kramer, MD, MACCOutgoing ACC President Christopher Kramer addresses scientific advances, global collaboration, advocacy wins and a year of leadership across the cardiovascular community.
- FUND-HF: Financial Support Improves Medication Adherence in Vulnerable PatientsProviding financial support early after hospital discharge to economically vulnerable patients with heart failure (HF) with reduced ejection fraction is feasible and significantly improved adherence to prescribed medications, according to results from the FUND-HF pilot trial presented during an Investigative Horizons session at ACC.26 in New Orleans and simultaneously published in JACC.
- IVUS-CHIP and OPTIMAL: IVUS-Guided vs. Angiography-Guided PCIWhen compared with angiography-guided PCI, IVUS-guided PCI was found to be not superior in patients with complex coronary arteries according to results from the IVUS-CHIP trial or in patients with unprotected left main coronary artery disease (LM-CAD) according to results from the OPTIMAL trial. Both trials were presented in a Late-Breaking Clinical Trial session at […]